GlassScriptPhysician profile
Lisa A Christman
NPI 1144214487
$4,862.32
in general payments reported to CMS, 2019-2025
26 companies · $1,323 in 2025
The $1,323 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $38.68 · 2021: $304 · 2022: $1,178 · 2023: $443 · 2024: $1,259 · 2025: $1,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,025.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,522.98 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $670.65 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $553.96 | 2019-2025 | |
| Amgen INC. | $333.45 | 2019-2025 | Otezla, Otezla |
| Pfizer INC. | $287.63 | 2019-2025 | |
| Lilly USA, LLC | $283.35 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $185.74 | 2019-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $106.78 | 2022-2024 | Sotyktu |
| Incyte Corporation | $103.68 | 2022-2025 | Opzelura |
| Ucb, INC. | $99.51 | 2025 | Bimzelx |
| Genzyme Corporation | $99.30 | 2022-2024 | |
| Arcutis Biotherapeutics, INC. | $97.18 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $93.58 | 2022-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $75.44 | 2024-2025 | Dupixent, Libtayo |
| Dermavant Sciences, INC. | $65.31 | 2022-2024 | Vtama |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $52.04 | 2019-2021 | |
| Botanix Sb INC | $48.89 | 2025 | Sofdra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.50 | 2022 | |
| Strata Skin Sciences, INC. | $23.11 | 2024 | Xtrac |
| Kyowa Kirin, INC. | $22.66 | 2025 | |
| Organon LLC | $21.07 | 2025 | Vtama |
| Lnhc, INC | $20.91 | 2025 | Zelsuvmi |
| Biofrontera INC. | $19.43 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Epi Health, LLC | $17.82 | 2022 | |
| Allergan, INC. | $17.20 | 2021 | |
| Galderma Laboratories, L.P. | $15.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Christman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.